$Global Testing (AYN.SG)$ It is a company one has to ignore ...

$Global Testing(AYN.SG)$
It is a company one has to ignore its earning due to high depreciation. Look at cashflow instead.

After two rounds of capital reductions, cash on hand now at US$5.7mil. For past two FY, company rake in FCF of about US$2mil. At current share price of S$0.35-0.45, one just need to wait for 3-5years to recoup the capital. What more, the company current testing lab sitting on a piece of freehold land booked at cost S$7.9mil in balance sheet bought donkeys years back. A rough check on land transaction can easily worth double. 

Potential catalyst? Waiting for management to call for another round of capital reduction would send the share price fly(last two capital reductions were 10c and 20c)

Risk? Revenue has dropping 30% compare to 5years ago, thought last two FY stabize at US$22mil. Things to watch out for.